The Diagnostic Imaging CT modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of CT across the healthcare continuum, from various cancer screenings, such as lung and colon, to cardiothoracic imaging, to appendicitis, and more.
November 20th 2024
While a large retrospective study found that interstitial lung abnormalities (ILAs) were evident on 1.7 percent of computed tomography (CT) scans, researchers found that 43.9 percent of ILAs, including fibrotic ILAs, were not reported.
19th Annual New York Lung Cancers Symposium®
November 16, 2024
Register Now!
Medical Crossfire®: How Does Recent Evidence on PARP Inhibitors and Combinations Inform Treatment Planning for Prostate Cancer Now and In the Future?
View More
Medical Crossfire®: How Do the Experts Select and Sequence Therapies to Optimize Patient Outcomes and Quality of Life in Advanced Prostate Cancer?
View More
Lung Cancer Tumor Board®: Enhancing Multidisciplinary Communication to Optimize Immunotherapy in Stage I-III NSCLC
View More
Clinical Vignettes™: The Experts Explain How They Integrate PET Imaging into Metastatic HR+ Breast Cancer Care Settings
View More
School of Breast Oncology® Live Video Webcast: Clinical Updates from San Antonio
View More
Annual Hawaii Cancer Conference
January 25-26, 2025
Register Now!
21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
February 8, 2025
View More
Community Practice Connections™: The 2nd Annual Hawaii Lung Cancers Conference®
View More
18th Annual New York GU Cancers Congress™
March 28-29, 2025
Register Now!
Clinical Case Vignette Series™: 41st Annual Miami Breast Cancer Conference®
View More
Medical Crossfire®: How Can Thoracic Teams Facilitate Optimized Care of Patients With Stage I-III EGFR Mutation-Positive NSCLC?
View More
Lung Cancer Tumor Board®: How Do Emerging Data for ICIs, BiTEs, ADCs, and Targeted Strategies Address Unmet Needs in the Therapeutic Continuum for SCLC?
View More
26th Annual International Lung Cancer Congress®
July 25-26, 2025
Register Now!
2025 International Symposium of Gastrointestinal Oncology (ISGIO)
September 12-13, 2025
Register Now!
Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection
View More
(CME Credit Only) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(MOC and CME Credit) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(CME Credit Only) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(MOC and CME Credit) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
Multiplexing CT scanner heads for center stage at AAPM meeting
July 20th 2007The seeds for what could be a new and much faster way of CT scanning will be planted next week, when researchers from the University of North Carolina at Chapel Hill unveil an approach involving nanotube x-ray sources and multiplexed data transmission.
CT vendors claim protocols cut coronary CTA dose
July 19th 2007The importance of CT protocols that limit patient exposure to radiation became more evident this week with publication of research suggesting that routine screening with coronary CT angiography could pose an increased lifetime risk of cancer.
Medicare outpatient payment proposal singles out imaging services for bundled payments
July 18th 2007Radiology and nuclear medicine are the focal points of proposed Medicare reforms that would bundle reimbursement in 2008 for seven categories of ancillary services covered by the Hospital Outpatient Prospective Payment System.
Michigan Blues examine coronary CTA in pilot program
July 11th 2007Blue Cross Blue Shield of Michigan and Blue Care Network are partnering with Michigan hospitals to examine whether coronary CT angiography, under certain circumstances, can be used as a complement or replacement for cardiac catheterization.
Cause of hearing loss emerges in patients with genetic disease
July 3rd 2007MR and CT can be the key to explaining sudden hearing loss. Explanations are most commonly associated with a benign tumor of the acoustic nerve, commonly called an acoustic neuroma but more appropriately described as a vestibular schwannoma. But radiologists may have to look elsewhere to find the answer in patients with a genetic disorder called von Hippel-Lindau disease. Again, however, MR may hold the key.
Boston hospital gives away nuclear medicine PACS
July 1st 2007Researchers at Beth Israel Deaconess Medical Center have developed a shareware nuclear medicine PACS software package that includes a display for fused PET/CT studies. It is freely available on the Internet, according to a web-exclusive article in the June issue of the American Journal of Roentgenology.
PET/CT predicts chemo response in lung cancer patients
June 22nd 2007FDG-PET/CT can accurately tell which lung cancer patients will have a successful response to chemotherapy, and therefore a longer survival, and which will not, according to a study in the May issue of the Journal of Nuclear Medicine. Findings may have important implications for patient management.
PET/CT fusion goes interactive
June 20th 2007Barco has put an interactive twist on the fusion of PET and CT data sets. The company demonstrated software at the Society for Imaging Informatics in Medicine meeting (June 7 to 10) that allows the user to blend data from CT and PET data sets to varying degrees, creating images that show more or less anatomic and functional data, at the user’s discretion.
Tc-99m-rtPA SPECT determines the age of deep vein thrombosis
June 15th 2007Research published in the June issue of the Journal of Nuclear Medicine suggests that radiolabeled recombinant tissue plasminogen activator can perform double duty for evaluations of deep vein thrombosis: It can diagnose the presence of DVT and distinguish between new and old thrombi. Peer-reviewed reports in the May medical literature reflect the growing value of medical imaging for diagnosing, assessing, and guiding the treatment of cardiovascular disease.
Philips captures high ground in PET/CT with time-of-flight
June 6th 2007Amid a stir created by competitors about high definition at the Society of Nuclear Medicine meeting, Philips Medical Systems quietly promoted what may be the ultimate answer to improved image quality: its proprietary time-of-flight PET/CT. Clinical data supporting the benefit of this approach are now being generated by the company’s Gemini TF (TruFlight, commercially launched in 2006).
Report from SNM: Society's new look embodies its strategic vision
June 6th 2007After more than a year of toggling with a rebranding process, the Society of Nuclear Medicine is no more. Along with a new face, the SNM acronym and the tagline "Advancing Molecular Imaging and Therapy" are the society's brand name from now on.
Report from SNM: Hybrid PET/MR imaging of brain debuts at annual meeting
June 5th 2007Researchers from Germany and the U.S. released findings from the first study showing images of the human brain acquired simultaneously by the two modalities of a hybrid PET/MR scanner. They released the data at the 2007 Society of Nuclear Medicine meeting being held in Washington, DC.
Report from SNM: PET guides management of gastrointestinal cancers
June 5th 2007FDG-PET can predict which patients with gastric or gastroesophageal cancer will benefit more from treatment and can thus assist decision-makers regarding the appropriate management of these patients, according to two studies presented Sunday at the 2007 Society of Nuclear Medicine meeting.
Report from SNM: PET study linking brain chemistry, behavior becomes Image of the Year
June 4th 2007Using PET with carbon-11-labeled monoamine oxidase A inhibitor clorgyline, researchers from the Brookhaven National Laboratory have found an association between MAO-A brain activity and violent behavior. Their study was selected as Image of the Year at the 2007 Society of Nuclear Medicine meeting in Washington, DC.
CMS may take aim at interpretation services
June 1st 2007Diagnostic imaging rests squarely within the sights of regulators, so don't be surprised if significant rule changes relating to imaging services may be in the offing. One likely target relates to how interpretation services, including those provided via teleradiology, can be performed and billed.
PET/CT hybrid imaging pioneers share dual-modality expertise
June 1st 2007University Hospital Zurich is well known for its work in PET/CT. The hospital installed one of the world's first PET/CT systems in March 2001 and currently operates two PET/CT scanners. Now radiologists and nuclear medicine physicians from around the world are being offered the chance to improve their dual-modality reading skills at this pioneering institution.
Molecular imaging takes top billing at 2007 SNM meeting
June 1st 2007The Society of Nuclear Medicine anticipates highlights galore at its upcoming 54th annual meeting in Washington, DC. But no other topic will receive more attention this year than the continuing integration of molecular imaging into the day-to-day doings of nuclear medicine specialists. Congress even declared the week of June 3 as Molecular Imaging Week to raise awareness on the emerging field.
CT extends reach of forensic science
May 30th 2007Autopsies have long been instrumental in documenting the cause of death from disease and crime. The procedure’s contribution to public welfare is beyond debate, but religious beliefs and family preferences have led to a decline in its use. Into this breach has stepped digital imaging in the form of CT, which lets forensic scientists investigate cases they would otherwise be prevented from working on.
ISMRM presentations demonstrate expanding reach of MR
May 29th 2007Research developments showcased the future of MR last week in Berlin, as Siemens demonstrated the feasibility of creating a hybrid of this modality with PET, while GE Healthcare exhibited the potential of 3T MR in virtual colonography.
Novel PET agent breaks through in Alzheimer’s diagnosis
May 25th 2007A new PET agent could help neuroimagers accurately tell the difference between the brains of Alzheimer’s disease patients and those of healthy aging individuals, according to a study published in the Journal of Nuclear Medicine.